EUVIMEDEUVIMED entdecken
Klinische Studie

Antinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus

Jérôme Granel, Helder Fernandes, Brigitte Bader-Meunier, Amandine Guth, Olivier Richer, Pascal Pillet, Guy Leverger, Stéphane Ducassou, Mony Fahd, Marlène Pasquet iD, Nathalie Garnier, Vincent Barlogis iD und 27 weitere

Blood · 18.04.2024 · 143 (16) · 1576-1585

DOI: 10.1182/blood.2023021884 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Blood, erschienen am 18.04.2024. Verfasst von Jérôme Granel und 38 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Clinical Immunology, Pellegrin Hospital, CIC1401, INSERM CICP, Bordeaux University Hospital, Bordeaux, France. Hauptthemen laut MEDLINE: Cytopenia, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune cytopenia (AIC) in children may be associated with positive antinuclear antibodies (ANA) and may progress to systemic lupus erythematosus (SLE). We evaluated the risk of progression to SLE of childhood-onset ANA-associated AIC. In the French national prospective OBS’CEREVANCE cohort, the long-term outcome of children with ANA-associated AIC (ANA titer ≥1/160) and a subgroup of children who developed SLE were described. ANA were positive in 355 of 1803 (20%) children with AIC. With a median follow-up of 5.8 (range, 0.1-29.6) years, 79 of 355 (22%) patients developed SLE at a median age of 14.5 (1.1-21.4) years; 20% of chronic immune thrombocytopenic purpura, 19% of autoimmune hemolytic anemia, and 45% of Evans syndrome. None of the patients with ANA-negative test developed SLE. Severe manifestations of SLE were observed in 21 patients, and 2 patients died. In multivariate analysis including patients with positive ANA within the first 3 months after AIC diagnosis, age >10 years at AIC diagnosis (relative risk [RR], 3.67; 95% confidence interval [CI], 1.18-11.4; P = .024) and ANA titer >1/160 (RR, 5.28; 95% CI, 1.20-23.17; P = .027) were associated with the occurrence of SLE after AIC diagnosis. ANA-associated AIC is a risk factor for progression to SLE, especially in children with an initial ANA titer >1/160 and an age >10 years at AIC diagnosis. ANA screening should be recommended in children with AIC, and patients with ANA should be monitored long-term for SLE, with special attention to the transition period. This trial was registered at www.ClinicalTrials.gov as #NCT05937828.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytopeniaLupus Erythematosus, SystemicAdolescentAdultChildHumansYoung AdultAntibodies, AntinuclearProspective StudiesRisk Factors

Substanzen

Antibodies, Antinuclear

Autor:innen und Institutionen

  • Paediatric Clinical Immunology, Pellegrin Hospital, CIC1401, INSERM CICP, Bordeaux University Hospital, Bordeaux, France.
  • Centre de Référence National des Cytopénies Auto-immunes de l'Enfant, Bordeaux, France.
  • Paediatric Haematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Paediatric Department, Pontarlier Hospital, Pontarlier, France.
  • Paediatric Oncology Immunology Haematology Unit, Armand-Trousseau University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Paediatric Haematology and Immunology Unit, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

ORCID-Profile: Marlène Pasquet, Vincent Barlogis, Corinne Guitton, Eric Jeziorski, Nathalie Cheikh, Isabelle Pellier, Sébastien Héritier, Nathalie Aladjidi

Zitieren

APA

Granel, J., Fernandes, H., Bader-Meunier, B., Guth, A., Richer, O., Pillet, P., Leverger, G., Ducassou, S., Fahd, M., Pasquet, M., Garnier, N., Barlogis, V., Guitton, C., Jeziorski, E., Thomas, C., Bayart, S., Cheikh, N., Paillard, C., Abou Chahla, W., …, & Aladjidi, N. (2024). Antinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus. Blood, 143(16), 1576-1585. https://doi.org/10.1182/blood.2023021884

Vancouver

Granel J, Fernandes H, Bader-Meunier B, Guth A, Richer O, Pillet P, et al. Antinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus. Blood. 2024;143(16):1576-1585. doi:10.1182/blood.2023021884

BibTeX
@article{Granel2024,
  author = {Granel, Jérôme and Fernandes, Helder and Bader-Meunier, Brigitte and Guth, Amandine and Richer, Olivier and Pillet, Pascal and Leverger, Guy and Ducassou, Stéphane and Fahd, Mony and Pasquet, Marlène and Garnier, Nathalie and Barlogis, Vincent and Guitton, Corinne and Jeziorski, Eric and Thomas, Caroline and Bayart, Sophie and Cheikh, Nathalie and Paillard, Catherine and Abou Chahla, Wadih and Chastagner, Pascal and Neven, Bénédicte and Millot, Frédéric and Lejeune, Julien and Li-Thiao Te, Valérie and Armari-Alla, Corinne and Briandet, Claire and Carausu, Liana and Deparis, Marianna and Piguet, Christophe and Benadiba, Joy and Marie-Cardine, Aude and Stephan, Jean-Louis and Pellier, Isabelle and Pluchart, Claire and Doré, Eric and Michaux, Katell and Héritier, Sébastien and Leblanc, Thierry and Aladjidi, Nathalie},
  title = {Antinuclear antibody–associated autoimmune cytopenia in childhood is a risk factor for systemic lupus erythematosus},
  journal = {Blood},
  year = {2024},
  volume = {143},
  number = {16},
  pages = {1576--1585},
  doi = {10.1182/blood.2023021884}
}
Kostenlos starten →